Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pradeesh Sivapalan

Showing results (41-50 of 178) with videos related to

Pageof 18
Sort By:
Journal of Clinical Medicine|August 7, 2019
Biomarkers of Acute Lung Injury The Individualized Approach: for Phenotyping, Risk Stratification and Treatment SurveillanceDaniel D Murray, Theis Skovsgaard Itenov, Pradeesh Sivapalan, et al.
Respiratory Research|September 12, 2024
Effect of low climate impact vs. high climate impact inhalers for patients with asthma and COPD-a nationwide cohort analysisBarbara Bonnesen, Josefin Eklöf, Tor Biering-Sørensen, et al.
Journal of Clinical Medicine|April 13, 2024
Risk of Mortality and Cardiovascular Events in Patients with Chronic Obstructive Pulmonary Disease Treated with Azithromycin, Roxithromycin, Clarithromycin, and AmoxicillinImane Achir Alispahic, Josefin Eklöf, Pradeesh Sivapalan, et al.
Journal of Clinical Medicine|May 16, 2020
Roflumilast in Severely Ill Patients with Chronic Obstructive Pulmonary Disease with Frequent Exacerbations: Risk of Pneumonia Hospitalization and Severe ExacerbationsImane Achir Alispahic, Rikke Sørensen, Josefin Eklöf, et al.
Respiratory Medicine Case Reports|July 11, 2022
Asymptomatic lung nodules in dental professionals: A diagnostic challengeAnuradha N Godallage, Shailesh Kolekar, Karen Ege Olsen, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 22, 2023
Psychiatric Adverse Effects of Montelukast-A Nationwide Cohort StudyAlexander Jordan, Louise Lindhardt Toennesen, Josefin Eklöf, et al.
Thorax|December 16, 2025
Disproportionate increase in COPD exacerbation risk for 3 months after discontinuing LAMA or ICS: insights from the FLAME trialAlexander G Mathioudakis, Sebastian Bate, Victoria Chatzimavridou-Grigoriadou, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|June 7, 2023
SARS-CoV-2 and risk of psychiatric hospital admission and use of psychopharmaceuticals: A nationwide registry study of 4,585,083 adult Danish citizensValdemar Rømer, Pradeesh Sivapalan, Josefin Eklöf, et al.
Biomedicines|June 2, 2021
Risk of Chronic Obstructive Pulmonary Disease Exacerbation in Patients Who Use Methotrexate-A Nationwide Study of 58,580 OutpatientsChristina Marisa Bergsøe, Pradeesh Sivapalan, Mohamad Isam Saeed, et al.
BMJ Open Respiratory Research|January 27, 2026
COPD and vitamin K antagonism: a cohort study of 1-year all-cause mortality and risk of hospitalisation due to a severe exacerbationBård-Emil Vang Vang Gundersen, Anna Kubel Vognsen, Josefin Eklöf, et al.
Pageof 18

Showing results (41-50 of 178) with videos related to

Sort By:
Pageof 18
Journal of Clinical Medicine|August 7, 2019
Biomarkers of Acute Lung Injury The Individualized Approach: for Phenotyping, Risk Stratification and Treatment SurveillanceDaniel D Murray, Theis Skovsgaard Itenov, Pradeesh Sivapalan, et al.
Respiratory Research|September 12, 2024
Effect of low climate impact vs. high climate impact inhalers for patients with asthma and COPD-a nationwide cohort analysisBarbara Bonnesen, Josefin Eklöf, Tor Biering-Sørensen, et al.
Journal of Clinical Medicine|April 13, 2024
Risk of Mortality and Cardiovascular Events in Patients with Chronic Obstructive Pulmonary Disease Treated with Azithromycin, Roxithromycin, Clarithromycin, and AmoxicillinImane Achir Alispahic, Josefin Eklöf, Pradeesh Sivapalan, et al.
Journal of Clinical Medicine|May 16, 2020
Roflumilast in Severely Ill Patients with Chronic Obstructive Pulmonary Disease with Frequent Exacerbations: Risk of Pneumonia Hospitalization and Severe ExacerbationsImane Achir Alispahic, Rikke Sørensen, Josefin Eklöf, et al.
Respiratory Medicine Case Reports|July 11, 2022
Asymptomatic lung nodules in dental professionals: A diagnostic challengeAnuradha N Godallage, Shailesh Kolekar, Karen Ege Olsen, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 22, 2023
Psychiatric Adverse Effects of Montelukast-A Nationwide Cohort StudyAlexander Jordan, Louise Lindhardt Toennesen, Josefin Eklöf, et al.
Thorax|December 16, 2025
Disproportionate increase in COPD exacerbation risk for 3 months after discontinuing LAMA or ICS: insights from the FLAME trialAlexander G Mathioudakis, Sebastian Bate, Victoria Chatzimavridou-Grigoriadou, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|June 7, 2023
SARS-CoV-2 and risk of psychiatric hospital admission and use of psychopharmaceuticals: A nationwide registry study of 4,585,083 adult Danish citizensValdemar Rømer, Pradeesh Sivapalan, Josefin Eklöf, et al.
Biomedicines|June 2, 2021
Risk of Chronic Obstructive Pulmonary Disease Exacerbation in Patients Who Use Methotrexate-A Nationwide Study of 58,580 OutpatientsChristina Marisa Bergsøe, Pradeesh Sivapalan, Mohamad Isam Saeed, et al.
BMJ Open Respiratory Research|January 27, 2026
COPD and vitamin K antagonism: a cohort study of 1-year all-cause mortality and risk of hospitalisation due to a severe exacerbationBård-Emil Vang Vang Gundersen, Anna Kubel Vognsen, Josefin Eklöf, et al.
Pageof 18